Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

0.6277
Delayed Data
As of Dec 09
 +0.0157 / +2.57%
Today’s Change
0.56
Today|||52-Week Range
1.42
-50.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues3.6M1.2M193.0K992.0K
 
 
 
 
 
Depreciation And Amortization6.0K5.0K2.0K0.00
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses9.7M8.4M7.3M6.6M
 
 
 
 
 
Research And Development3.9M6.0M5.6M4.4M
 
 
 
 
 
Total Operating Expenses9.7M8.4M7.3M6.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.1M-7.2M-7.1M-5.6M
 
 
 
 
 
Extraordinary Credit0.000.000.001.2M
 
 
Extraordinary Charge--0.00-996.0K0.00
 
 
Interest Expense On Debt425.0K386.0K468.0K551.0K
 
 
 
 
 
Other Expenses-44.0K-9.0K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.6M-7.6M-8.6M-5.0M
 
 
 
 
 
Income Taxes0.00-100.0K0.000.00
 
 
Net Income-6.6M-7.7M-8.6M-5.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS58.1M58.2M66.9M75.9M
 
 
 
 
 
Shares To Calculate EPS Diluted58.1M58.2M66.9M75.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.11-$0.13-$0.13-$0.07
 
 
 
 
 
EPS Diluted-$0.11-$0.13-$0.13-$0.07